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Abstract: Background/aim: The Zurich Chronic Middle Ear Questionnaire (ZCMEI-21) is a newly-
developed German-language questionnaire. The purpose of this study was to analyze the quality of
life (QoL) of chronic otitis media (COM) patients and translate, transculturally adapt, and validate
the ZCMEI-21 into Turkish. Materials and methods: Based on internationally accepted guidelines, the
ZCMEI-21 was translated into Turkish. To assess its validity, the total score of the ZCMEI-21-Tur
was compared to the scores taken from the original validation study and a question that was directly
related to the health-related QoL (HRQoL), as well as the general criterion EQ-5D-5L. Questionnaires
were completed by healthy volunteers and the results were evaluated statistically. Results: A total of 80
COM patients and 40 healthy volunteers were prospectively enrolled in this study. Regarding internal
consistency, the questionnaire showed a Cronbach ฀ of 0.94, which indicated high internal consistency.
Moreover, internal consistency was also determined to be excellent for the Cronbach ฀ of the individual
subscales, as follows: ear sign symptoms, 0.79; hearing, 0.83; psychosocial impact, 0.91, and medical
resources, 0.84. Conclusions: The ZCMEI-21 was translated into Turkish and validated. Therefore, the
ZCMEI-21-Tur was suitable for use in assessing HRQoL in adult patients with COM.
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1. Introduction
Chronic otitis media (COM) affects approximately 2% of 
the population. Otorrhea, hearing loss, tinnitus, vertigo, 
and malodorous discharge are serious problems in 
patients with COM. In particular, hearing loss and odor-
related problems may cause problems for the patient when 
communicating with their environment and consequently, 
problems in education, and professional and social life [1]. 
Like many other chronic diseases, COM is a triggering 
factor for chronic stress and psychological problems. The 
parameters used for evaluation in diagnosis and the choice 
of treatment are related to the disease, but do not reflect 
the personal experiences of the patients. Questionnaires 
that assess the patients subjectively are needed to assess 
their challenges and motivation for treatment [2].
The Zurich Chronic Middle Ear Questionnaire 
(ZCMEI-21) is a newly-developed German-language 
questionnaire that comprehensively evaluates the 
symptoms and psychosocial effects of health-related 
quality of life (HRQoL) in COM patients [3]. The English, 
German, and Italian versions were found to be valid and 
consistent; however, English, German, and Italian belong 
to the Indo-European language family. Validation of a 
Japanese language version was performed and found to be 
suitable [4–6]. Japanese is from the Ural-Altaic language 
family, like Turkish, and has a similar structure. However, 
the only ear disease-related questionnaire translated into 
Turkish was the chronic otitis media questionnaire-12 
(COMQ-12), which only briefly mentions lifestyle 
effects and is heavily oriented around hearing-related 
impairment of HRQoL [7]. Therefore, there is a need for a 
measurement to evaluate patients more comprehensively. 
In this study, the aim was to translate the ZCMEI-21 
into Turkish and evaluate its cross-cultural adaption and 
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validation in order to assess the quality of life (QoL) of 
patients with COM.
2. Material and methods
2.1. Patients
Ethical permission approval was obtained from the Ethics 
Committee of our institution under approval number 
48670771-000-8112. Informed consent form was given by 
all of the participants.
2.2. Inclusion criteria
Preoperative and postoperative patients with preoperative 
or postoperative COM simplex (OMCS) or COM with 
cholesteatoma (OMCC) who were older than 18 years old 
were invited to participate in the study. The control group 
included patients with no ear complaints. 
2.3. Translation and cross-cultural adaptation
Translation from German to Turkish was completed 
by 2 professional translators. These 2 inventories were 
then combined into a single file by physicians and 
translators (ZCMEI-21-Tur, v1). This first version was 
applied to 5 patients. The problems that the patients 
had in understanding the questions were evaluated, 
and minor changes were made (ZCMEI21-Tur, v2). A 
third professional translation agent then did a German 
translation of the final version, and the ZCMEI-21-Tur 
was changed into a conceptually equalized translation 
(ZCMEI-21-Tur, v3). The second pilot test (cognitive 
questioning 2) was performed with another 5 COM 
patients. No changes were made. The final version of the 
questionnaire (ZCMEI-21-Tur) was applied to both groups 
of patients and healthy volunteer subjects (Figure 1).
2.4. Validation
The original German questionnaire was administered 
to patients via an electronic version. The patients 
were interviewed face-to-face and administered the 
questionnaire in person. The questionnaires (ZCMEI-21-
Figure 1. Flow chart of the translation and validation approach.
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Tur and EQ-5D-5L) were administered by a single resident 
to 84 patients who met the inclusion criteria and to 40 
healthy volunteers. Of the patients, 4 were excluded from 
the study due to incomplete questionnaires. Question 22, 
which was in the original validation study, was included 
in the questionnaire. This was a general question that 
addressed HRQoL directly: “The disease in my ear worsens 
my quality of life”. 
The EQ-5D-5L version consists of 5 main questions, 
and each question has 5 answers. The 5 questions cover 
the mobility of the patient, self-care, daily activities, and 
pain/discomfort related to COM, and anxiety/depression 
caused by disease [8]. Patients choose from 1- to 5-point 
Likert-type appropriate responses. It also includes a visual 
analog scale (VAS) score. This VAS is based on describing 
their health status on a scale from 0 to 100, with 100 
corresponding to the best health condition. The survey 
was completed by 120 people and the survey results were 
evaluated statistically.
2.5. Statistical analysis
Values were reported as the mean ± SD or as an absolute 
number and percentage. The item total-correlation was 
calculated in order to evaluate whether it correlated with 
the total score. An item total-correlation of ≥0.3 indicated 
that a question correlated well with the total score and 
represented 1 criterion for a strong item. Construct 
validity was established using a question (question 22) 
that directly assessed HRQoL. For assessing the reliability 
of the ZCMEI-21-Tur, internal consistency, as an indicator 
of reliability, was determined using the Cronbach α. 
Concurrent validity was determined by comparing the 
ZCMEI-21-Tur total scores and subscores to the EQ-5D 
descriptive system and VAS scores using the Spearman 
rank correlation and linear regression analysis, including 
mean prediction intervals. Statistical significance was 
accepted as P < 0.05.
3. Results
A total of 80 patients and 40 controls completed the ZCMEI-
21-Tur and EQ-5D-5L. Thus, a total of 120 participants, 
with a mean age of 30.4 ± 9.2 (between 18 and 45) years 
in the validation group and 29.9 ± 8.9 (18–44) years in the 
control group, were included in the study. OMCC was the 
diagnosis in 29 (36%) patients and OMCS was seen in 51 
(64%) patients. At the time of fulfillment of the ZCMEI-
21-E, 62 (78%) patients had already undergone surgery 
for COM. Additionally, 40 had undergone tympanoplasty 
and 22 had tympanomastoidectomy. The air conduction 
threshold of the patients was 46.3 ± 8.2 dB HL, and the 
bone conduction threshold was 26.6 ± 6.9 dB HL. The air 
conduction threshold of the control group was 15.6 ± 6.1 
db HL, while the bone conduction threshold was 9.5 ± 4.5 
dB HL. Detailed characteristics of the patients and control 
group are given in Table 1. 
Concerning the single-item descriptive statistics of the 
ZCMEI-21-Tur, it was found that the answers were well 
distributed and the full range of answers was used on every 
question. Item-total correlations of all of the items were 
well above 0.3 (for detailed descriptive statistics, see Table 
2). An item-total correlation of ≥0.3 indicated that an item 
correlated well with the total score, representing 1 criterion 
for a strong item. Assessing the internal consistency as 
an indicator of reliability, the questionnaire showed a 
Cronbach α of 0.94, indicating high internal consistency. 
Adequate to excellent internal consistency was also found 
for the individual subscales (Table 2).





Male to female ratio 38:42 19:21
Age (mean ± SD) (years) 30.36 ± 9.22 29.87 ± 8.93
COM, type—no. (%) N/A
OMCC 29 (36 %)
OMCS 51 (64 %)
Affected ear(s)—no. (%) N/A
Right 48 (60 %)
Left 29 (36 %)
Both 3 (4 %)
Previous operation due to COM—no. (%) 62 (78 %) N/A
COM, chronic otitis media; OMCS, otitis media chronica simplex; OMCC, otitis media 
chronica cholesteatomatosa.
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When comparing the total score and direct HRQoL 
question, a strong correlation (r = 0.69, P < 0.001) was 
found. When comparing the ZCMEI-21-Tur total score 
and EQ-5D scores, strong correlations (r = 0.76, P < 0.001 
for the descriptive system score and r = 0.70, P < 0.001 for 
the VAS score) were found. The total score of the ZCMEI-
21-Tur and the scores of its subscales, comprising ear signs 
and symptoms (questions 1–5), hearing (questions 6–10), 
psychosocial impact (questions 11–18), and medical 
resources (questions 19–21) are given in Table 3 and 
Figures 2, 3A–3C, and 4A–4C).
Because a significant portion of the validation group 
had already undergone surgical treatment for COM (78%), 
the differences between the ZCMEI-21-Tur total scores of 
the patients who had undergone surgery and those who 
had not undergone surgery were assessed. The mean 
ZCMEI-21-Tur score patients who had undergone surgery 
was 29.0 ± 8.4 and for those who had not undergone 
surgery it was 41.9 ± 12.8 (P < 0.001). The results of the 
comparison of the ZCMEI-21-Tur scores between the 
patients with COM and the control group are given in 
Table 4. The patients had higher mean total scores and SDs 
when compared to the control group (P < 0.001).
4. Discussion
In recent years, patient-reported outcome measures 
(PROMs) have become of great importance for follow-
up, evaluation, and research [9]. There are 3 commonly 
used questionnaires for PROMs in adult patients with 
COM, comprising the chronic ear survey (CES, English), 
Chronic Otitis Media Outcome Test-15 (COMOT-15, 
German), and COMQ-12 (English) [10]. Each survey 
highlights a different area. In this study, the ZCMEI-21 
was successfully translated into Turkish and validated.
Table 2. Descriptive statistics of the individual items (ZCMEI-21-Turkish).
Mean SD Min–max ITC Cronbachα
I. Ear signs and symptoms 0.79
1. Ear pain 1.00 0.81 0–3 0.66
2. Discharge 0.65 0.81 0–3 0.75
3. Itching 0.90 1.00 0–4 0.42
4. Feeling of pressure 0.84 0.74 0–2 0.60
5. Balance 0.43 0.63 0–2 0.48
II. Hearing 0.83
6. Tinnitus 1.46 1.42 0–4 0.48
7. Hearing (filter question) 1.84 1.01 0–4 0.67
8. When many people speak at the same time 1.65 1.06 0–4 0.70
9. Telephone, alarm clock 1.81 1.26 0–4 0.65
10. Fear of not hearing other people 1.53 1.12 0–4 0.64
III. Psychosocial impact 0.91
11. Impact of ear symptoms on HRQoL 1.96 1.35 0–4 0.81
12. Protection from water 1.00 1.30 0–4 0.55
13. Activities with family and friends 1.78 1.34 0–4 0.74
14. In public (e.g., school/occupation, shopping) 1.35 1.03 0–4 0.67
15. Making contact with other people 1.60 1.34 0–4 0.79
16. Quality of sleep 2.89 1.38 0–4 0.79
17. Sadness 2.85 1.18 0–4 0.71
18. Fear that the ear problems may persist 1.73 1.11 0–4 0.63
IV. Medical resources 0.84
19. Medical consultations 1.68 0.99 0–4 0.71
20. Antibiotics (oral) 1.26 1.06 0–3 0.75
21. Ear drops 1.75 1.17 0–4 0.64
ITC: item total correlation; min: lowest value; max: highest value; α: Cronbach α for the subscales.
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The CES was developed by Nadol et al. in 2000 and 
contains 13 questions on 3 main topics: activity restriction, 
symptoms, and medical resources. It does not include 
questions about tinnitus or dizziness, and it also does not 
evaluate the psychology or decrease in QoL of the patient 
[1,10]. The COMOT-15 was introduced by Baumann et 
al. in 2009. It includes questions about ear symptoms, 
hearing, and mental status. It does not inquire about 
anxiety, depression, or social isolation, which have specific 
importance in COM [11,12]. The COMQ-12 questionnaire 
was developed in 2014 by Phillips et al. It contains 12 
questions in 4 categories, comprising symptoms, lifestyle 
and work, healthcare, and general impact. Although it 
contains questions about impact on lifestyle and work, it 
does not include questions that meet the psychological 
and social dimensions of COM [13].
In 2016, Bächinger et al. [3] developed a new German 
electronic questionnaire, ZCMEI-21, for the comprehensive 
measurement of HRQoL, which aimed to evaluate 
adult COM patients in all aspects of the disease and its 
Table 3. Comparison and correlation of the total scores and subscales scores of the ZCMEI-21 and ZCMEI-21-Turkish and 
EQ-5D-5L.
Current study
ZCMEI-21-Turkish (n = 80)
Original validation study
ZCMEI-21 (n = 76)
ZCMEI-21-Turkish/ZCMEI-21 total score (±SD) 31.9 ± 10.9 29.7 ± 16.1
I. Ear signs and symptoms 3.8 ± 2.8 5.1 ± 3.9
II. Hearing 8.3 ± 3.4 8.5 ± 5.2
III. Psychosocial impact 15.2 ± 6.1 13.1 ± 7.9
IV. Medical resources 4.7 ± 2.5 3.0 ± 2.3
EQ-5D-5L (±SD)
Descriptive system score 0.90 ± 0.13 0.92 ± 0.14
VAS score 74.8 ± 16.8 N/A
Total score correlation*
To question directly assessing HRQoL (Q22) r = 0.69, P ˂ 0.001 r = 0.74, P ˂ 0.001
To EQ-5D-5L descriptive system score r = 0.76, P ˂ 0.001 r = 0.60, P ˂ 0.001
To EQ-5D VAS score r = 0.70, P ˂ 0.001 N/A
*Spearman’s rank correlation coefficient, P-value.
Figure 2. Spearman’s rank correlation of the ZCMEI-21-Turkish total scores and the 
question directly addressing HRQoL (0 on the x-axis corresponds to no impact on 
HRQoL, as indicated by the question directly addressing HRQoL, whereas 4 indicates 
the greatest impact; Spearman’s rank correlation.
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consequences on HRQoL. Although the ZCMEI-21 is based 
on current surveys (CES, COMOT-15), it varies in several 
aspects that provide certain advantages. The ZCMEI-21 
evaluates classic ear symptoms (e.g., pain, discharge, 
dizziness/balance problems, hearing impairment, and 
tinnitus). The pain-related element is particularly important 
concerning patients who have recently undergone surgery. 
The ZCMEI-21 is classified into 4 subheadings: I) ear signs 
and symptoms, II) hearing, III) psychosocial effects, and 
IV) medical resources. Regarding the psychological and 
social aspects of the patients, the ZCMEI-21 is valuable 
in the evaluation of neglected aspects of the disease. 
Baechinger et al. administered the ZCMEI-21 to 76 patients 
with COM. They compared the total score of the ZCMEI-21 
with a question that directly reflected HRQoL and the 
total score of the EQ-5D questionnaire. The ZCMEI-21 
total score and EQ-5D descriptive system score were only 
moderately correlated (r = 0.60, P < 0.0001), while the 
ZCMEI-21 total score and the question directly related to 
HRQoL showed a strong correlation (r = 0.74, P < 0.0001). 
Verification showed a Cronbach α of 0.91 and excellent 
internal consistency. In addition, the ZCMEI-21 was able to 
differentiate patients with COM from healthy participants 
(P < 0.0001). Thus, good sensitivity was obtained. As a 
result, sufficient information was obtained about reliability 
and validity to extend the application of the ZCMEI-21 to 
quantify HRQoL in patients with COM.
The current study of the ZCMEI-21-Tur revealed a 
Cronbach α of 0.94, indicating higher internal consistency 
than the Japanese and English versions. Adequate to 
excellent internal consistency was also found for the 
individual subscales. When comparing the ZCMEI-21-
Tur total score and the question directly assessing HRQoL, 
a strong correlation (r = 0.69, P < 0.001) was detected. 
When comparing the ZCMEI-21-Tur total score and the 
EQ-5D scores, strong correlations were obtained (r = 0.76, 
P < 0.001 for the descriptive system score and r = 0.70, P < 
0.001 for the VAS score).
Figure 3. (A–C) Spearman’s rank correlation between the ZCMEI-21-Turkish subscale scores and EQ-5D descriptive systems score. 
Solid line represents linear regression, dashed lines represent 95% prediction intervals. A) r = 0.71, P ˂ 0.001. B) r = 0.69, P ˂ 0.001. C) 
r = 0.65, P ˂ 0.001.
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There were some limitations of the study, including the 
limited number of participants and heterogeneous COM 
group. Both preoperative and postoperative patients were 
included the study, which may have seemed confusing, but 
the original paper, English, and Japanese validations were 
designed to include both; hence the current study did as 
well. On the other hand, the total number of participants 
was sufficient to perform the statistical analysis. 
Conclusion: The ZCMEI-21-Tur is suitable for use 
in assessing HRQoL in adult patients with COM. It may 
therefore be used for following-up patients for research 
purposes, as well as in clinical practice.
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Figure 4. (A–C) Spearman’s rank correlation between the ZCMEI-21-Turkish subscale scores and EQ-5D VAS score. Solid line represents 
linear regression, dashed lines represent 95% prediction intervals. A) r = 0.48, P ˂ 0.001. B) r = 0.68, P ˂ 0.001. C) r = 0.64, P ˂ 0.001.
Table 4. Comparison of the ZCMEI-21-Turkish scores between patients with COM and healthy 
participants serving as the controls (mean ± SD, Mann–Whitney U test).
COM (validation group) Controls P-value
I. Ear signs and symptoms 3.8 ± 2.8 0.7 ± 0.5 ˂0.001
II. Hearing 8.3 ± 3.4 0.0 ± 0.0 ˂0.001
III. Psychosocial impact 15.2 ± 6.1 0.0 ± 0.0 ˂0.001
IV. Medical resources 4.7 ± 2.5 0.0 ± 0.0 ˂0.001
Total score 31.9 ± 10.9 0.7 ± 0.5 ˂0.001
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